Cited by 548Parkinson's Disease Mechanisms and TreatmentsMitochondrial Function and PathologyMetabolism and Genetic Disorders

Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study

Luoma, Petri, Melberg, Atle, Rinne, Juha O, Kaukonen, Jyrki A, Nupponen, Nina N, Chalmers, Richard M, Oldfors, Anders, Rautakorpi, Ilkka +4 more·2004·The Lancet

Abstract

Background Mutations in the gene encoding mitochondrial DNA polymerase gamma (POLG), the enzyme that synthesises mitochondrial DNA (mtDNA), have been associated with a mitochondrial disease-autosomal dominant or recessive progressive external ophthalmoplegia-and multiple deletions of mtDNA. Mitochondrial dysfunction is also suspected to participate in the pathogenesis of Parkinson's disease. However, no primary gene defects affecting mitochondrial proteins causing mendelian transmission of parkinsonism have been characterised. We aimed to analyse the gene sequence of POLG in patients with progressive external ophthalmoplegia and their healthy relatives.Methods In seven families of various ethnic origins we assessed patients with progressive external ophthalmoplegia and unaffected individuals by clinical, biochemical, morphological, and molecular genetic characterisation and positron emission tomography (PET).Findings We recorded mutations in POLG in members of all seven families. Clinical assessment showed significant cosegregation of parkinsonism with POLG mutations (p<0.0001), and PET findings were consistent with dopaminergic neuron loss. Post-mortem examination in two individuals showed loss of pigmented neurons and pigment phagocytosis in substantia nigra without Lewy bodies. Furthermore, most women with progressive external ophthalmoplegia had early menopause-before age 35 years. The POLG gene defect resulted in secondary accumulation of mtDNA deletions in patients' tissues.Interpretation Dysfunction of mitochondrial POLG causes a severe progressive multisystem disorder including parkinsonism and premature menopause, which are not typical of mitochondrial disease. Cosegregation of parkinsonism and POLG mutations in our families suggests that when defective, this gene can underlie mendelian transmission of parkinsonism.Relevance to practice Awareness that mitochondrial POLG mutations can underlie parkinsonism is important for clinicians working in diagnosis of movement disorders, as well as for studies of the genetics of Parkinson's disease. Further, progressive external ophthalmoplegia with muscle weakness and neuropathy can mask symptoms of parkinsonism, and clinicians should pay special attention to detect and treat parkinsonism in those individuals.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)16983-3

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A., Nupponen, N. N., Chalmers, R. M., Oldfors, A., Rautakorpi, I., Peltonen, L., Majamaa, K., Somer, H., & Suomalainen, A.
Affiliations
  • University of Helsinki (FI)
  • Uppsala University Hospital (SE)
  • University of Turku (FI)
  • National Hospital for Neurology and Neurosurgery (GB)
  • Sahlgrenska University Hospital (SE)
  • Lapland Central Hospital (FI)
  • University of Oulu (FI)
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-09
Volume
364
Issue
9437
Pages
875-882
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2130588024
Cited by
548
References
41
Citations by year
2026: 8 · 2025: 9 · 2024: 13 · 2023: 15 · 2022: 23 · 2021: 27 · 2020: 28 · 2019: 18 · 2018: 23 · 2017: 24 · 2016: 31 · 2015: 17 · 2014: 29 · 2013: 32 · 2012: 26
FWCI
21.24
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Sigrid Juséliuksen Säätiö
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
parkinsonism, premature menopause, mitochondrial DNA polymerase gamma, POLG mutations, chronic progressive external ophthalmoplegia, mitochondrial disease, mitochondrial DNA deletions, dopaminergic neuron loss, substantia nigra, co-segregation, Mendelian inheritance, Parkinson's disease genetics, movement disorders
MeSH terms
DNA Polymerase gamma, Adult, Brain, DNA-Directed DNA Polymerase, DNA, Mitochondrial, Female, Humans, Male, Menopause, Premature, Middle Aged, Mutation, Pedigree, Tomography, Emission-Computed, Ophthalmoplegia, Chronic Progressive External, Sequence Analysis, DNA, Age of Onset, Parkinsonian Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review